Decreased m6A modification by METTL3 knockdown in the hippocampus in vivo resulted in elevated oxidative stress, aberrant cell cycle events, activation of apoptosis and neurodegeneration as well as cognitive deficits similar to that of AD. This evidence concerns the gene METTL3 and Alzheimer disease.